WebCardioprotection for 20 Years for Children With Cancer “Dexrazoxane (Totect, Zinecard) provides long-term cardioprotection for children treated with doxorubicin for cancer, and its co-administration with doxorubicin should be standard of care, say researchers in a report publishedpublished January 20 in the Journal of Clinical Oncology… Underused in Children WebApr 10, 2024 · The initial cumul ative doses of doxorubicin used in oste-osarcoma were high, exceeding 450 mg/m. 2. These doses. ... Dexrazoxane has been used in comb ination of doxorubi-cin to prevent heart ...
Totect, Zinecard (dexrazoxane) dosing, indications, interactions ...
WebOct 22, 2015 · Dosing is a 10:1 ratio of dexrazoxane to doxorubicin; doxorubicin is typically given at 75 mg/m2, so dexrazoxane dosing would be 750 mg/m2. In the event of a national shortage of dexrazoxane, 72-hour infusional doxorubicin can be used instead of dexrazoxane and bolus doxorubicin.. WebUse of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. Cancer Prev Control 1999 ;3: 145 - 159 Medline bing black history month quiz 2022
The Role of Topoisomerase IIβ in the Mechanisms of Action of ... - PubMed
WebFeb 20, 2024 · This medicine is not given with your first dose of doxorubicin, but only after you've received prior doxorubicin doses up to a certain total amount. Dosing information. Usual Adult Dose for Cardiomyopathy Prophylaxis: Dosage ratio of dexrazoxane to doxorubicin is 10:1 (e.g. 500 mg/m2 dexrazoxane to 50 mg/m2 doxorubicin) WebJul 18, 2024 · Dexrazoxane for injection is a cytoprotective agent indicated for reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg/m 2 and who will continue to receive doxorubicin therapy to maintain tumor … WebDexrazoxane should only be used in adult patients with advanced or metastatic breast cancer. The benefits of dexrazoxane do not outweigh its risks in children and adolescents. Dexrazoxane should only be used in adult patients who have already received a minimum cumulative anthracycline dose of 300 mg/m 2 of doxorubicin, or 540 mg/m 2 of epirubicin. bing blocking chrome